This marks the first dedicated transcatheter heart valve approved for high-risk patients with symptomatic severe AR.
The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition ...
The FDA approved the Trilogy Transcatheter Heart Valve System for the treatment of symptomatic severe aortic regurgitation, ...
Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, outcomes were similar among patients who had undergone transcatheter aortic-valve ...
Credit: Getty Images Clinicians must be vigilant for subtle signs of BAV in children. Once diagnosed, management decisions should be individualized. Bicuspid aortic valve (BAV) is the most common ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
HEART valve disease is an often overlooked condition, yet it affects millions of people worldwide, particularly older adults.
A 74-year-old man presents to the emergency department with a 1-day history of severe chest and back pain. He has a history of hypertension and has run out of medication. He has no history of similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results